Abbreviations: 2-AG, 2-arachidonoylglycerol; 5-HT 1A , serotonin 1A receptor; 5-HT 1B , serotonin 1A receptor; 5-HT 2A (Htr2a), serotonin 2A receptor; 5-HT 3 , serotonin 3 receptor; AEA, anandamide; AR, adrenoceptors; AUD, alcohol use disorder; BA, basal nucleus of the amygdala; BLA, basolateral nucleus of the amygdala; BMA, basomedial nucleus of the amygdala; BNST, bed nucleus of the stria terminalis; CALCRL (Calcrl), calcitonin receptor-like; CART (Cartpt), cocaine and amphetamine regulated transcript; CB 1 , cannabinoid type 1; CB 2 , cannabinoid type 2; CeA, central nucleus of the amygdala; CeC, capsular division of the CeA; CeL, lateral division of the CeA; CeM, medial division of the CeA; CNS, central nervous system; CoA, cortical nucleus of the amygdala; CRF (Crh), corticotrophin releasing factor; CRF 1 (Crhr1), CRF receptor 1; D 1 R (Drd1), dopamine D1 receptor; D 2 R (Drd2), dopamine D2 receptor; EGFP, enhanced green fluorescent protein; FAAH, fatty acid amide hydrolase; FISH, fluorescent in-situ hybridization; GAL 1 , galanin 1 receptor; GAL 2 , galanin 2 receptor; GAL 3 , galanin 3 receptor; GPCR, G protein-coupled receptors; HPA, hypothalamic-pituitary-adrenal axis; IEG, early immediate gene; IHC, immunohistochemistry; IPSC, inhibitory postsynaptic potentials; ITC, intercalated cells of the amygdala; KO, knockout; LA, lateral basal nucleus of the amygdala; LC, locus coeruleus; LDB, light-dark box LH, lateral hypothalamus; MAGL, monoacylglycerol lipase; MeA, medial nucleus of the amygdala; mSP, Marchigian Sardinian alcohol-preferring rat; N/O-FQ